Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Markovic

Showing results (321-330 of 368) with videos related to

Pageof 37
Sort By:
Leukemia & Lymphoma|May 4, 2012
Absolute monocyte/lymphocyte count prognostic score is independent of immunohistochemically determined cell of origin in predicting survival in diffuse large B-cell lymphomaLuis F Porrata, Kay Ristow, Thomas M Habermann, et al.
Mayo Clinic Proceedings|June 2, 2011
Mayo Clinic consensus recommendations for the depth of excision in primary cutaneous melanomaTravis E Grotz, Svetomir N Markovic, Lori A Erickson, et al.
Mayo Clinic Proceedings|July 11, 2008
Malignant melanoma in the 21st century: the emerging molecular landscapeAleksandar Sekulic, Paul Haluska, Arlo J Miller, et al.
Medrxiv : the Preprint Server for Health Sciences|June 12, 2025
Inflammatory arthritis immune related adverse events represent a unique autoimmune disease entity primarily driven by T cells, but likely not autoantibodiesXingxing Zhu, Yue Yu, Yanfeng Li, et al.
Journal of Neurosurgery|October 25, 2023
The longitudinal risk of hemorrhage of melanoma brain metastases after Gamma Knife radiosurgerySukwoo Hong, Samantha M Bouchal, Megan M J Bauman, et al.
Scientific Reports|February 3, 2018
Contraction of T cell richness in lung cancer brain metastasesAaron S Mansfield, Hongzheng Ren, Shari Sutor, et al.
Leukemia & Lymphoma|August 20, 2005
The effect of absolute lymphocyte count recovery kinetics on survival after autologous stem cell transplantation for non-Hodgkin's lymphomaYinlee Yoong, Luis F Porrata, David J Inwards, et al.
Journal for Immunotherapy of Cancer|August 21, 2020
Therapeutic plasma exchange clears circulating soluble PD-L1 and PD-L1-positive extracellular vesiclesJacob J Orme, Elizabeth Ann L Enninga, Fabrice Lucien-Matteoni, et al.
American Journal of Clinical Oncology|June 7, 2007
A phase II study of ABT-510 (thrombospondin-1 analog) for the treatment of metastatic melanomaSvetomir N Markovic, Vera J Suman, Ravi A Rao, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 9, 2012
Phase II trial of intravenous administration of Reolysin(®) (Reovirus Serotype-3-dearing Strain) in patients with metastatic melanomaEvanthia Galanis, Svetomir N Markovic, Vera J Suman, et al.
Pageof 37

Showing results (321-330 of 368) with videos related to

Sort By:
Pageof 37
Leukemia & Lymphoma|May 4, 2012
Absolute monocyte/lymphocyte count prognostic score is independent of immunohistochemically determined cell of origin in predicting survival in diffuse large B-cell lymphomaLuis F Porrata, Kay Ristow, Thomas M Habermann, et al.
Mayo Clinic Proceedings|June 2, 2011
Mayo Clinic consensus recommendations for the depth of excision in primary cutaneous melanomaTravis E Grotz, Svetomir N Markovic, Lori A Erickson, et al.
Mayo Clinic Proceedings|July 11, 2008
Malignant melanoma in the 21st century: the emerging molecular landscapeAleksandar Sekulic, Paul Haluska, Arlo J Miller, et al.
Medrxiv : the Preprint Server for Health Sciences|June 12, 2025
Inflammatory arthritis immune related adverse events represent a unique autoimmune disease entity primarily driven by T cells, but likely not autoantibodiesXingxing Zhu, Yue Yu, Yanfeng Li, et al.
Journal of Neurosurgery|October 25, 2023
The longitudinal risk of hemorrhage of melanoma brain metastases after Gamma Knife radiosurgerySukwoo Hong, Samantha M Bouchal, Megan M J Bauman, et al.
Scientific Reports|February 3, 2018
Contraction of T cell richness in lung cancer brain metastasesAaron S Mansfield, Hongzheng Ren, Shari Sutor, et al.
Leukemia & Lymphoma|August 20, 2005
The effect of absolute lymphocyte count recovery kinetics on survival after autologous stem cell transplantation for non-Hodgkin's lymphomaYinlee Yoong, Luis F Porrata, David J Inwards, et al.
Journal for Immunotherapy of Cancer|August 21, 2020
Therapeutic plasma exchange clears circulating soluble PD-L1 and PD-L1-positive extracellular vesiclesJacob J Orme, Elizabeth Ann L Enninga, Fabrice Lucien-Matteoni, et al.
American Journal of Clinical Oncology|June 7, 2007
A phase II study of ABT-510 (thrombospondin-1 analog) for the treatment of metastatic melanomaSvetomir N Markovic, Vera J Suman, Ravi A Rao, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 9, 2012
Phase II trial of intravenous administration of Reolysin(®) (Reovirus Serotype-3-dearing Strain) in patients with metastatic melanomaEvanthia Galanis, Svetomir N Markovic, Vera J Suman, et al.
Pageof 37